Effects of Cladribine Tablets on the PK of Microgynon®

Clinical trial NCT03745144 · COMPLETED

Trial details

NCT number: NCT03745144
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis (RMS)

Start date: 2019-01-17
Primary completion: 2022-09-02
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.